Form 8-K - Current report:
SEC Accession No. 0001641172-25-002147
Filing Date
2025-04-01
Accepted
2025-04-01 17:23:09
Documents
14
Period of Report
2025-03-31
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41387
  Complete submission text file 0001641172-25-002147.txt   261545

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cdt-20250331.xsd EX-101.SCH 3839
3 XBRL DEFINITION FILE cdt-20250331_def.xml EX-101.DEF 26712
4 XBRL LABEL FILE cdt-20250331_lab.xml EX-101.LAB 36866
5 XBRL PRESENTATION FILE cdt-20250331_pre.xml EX-101.PRE 25336
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6017
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41245 | Film No.: 25800975
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)